Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2003
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313707A1 Quinoline derivatives as anti-inflammation agents
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313699A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
05/28/2003EP1313697A2 Immunoregulatory compounds, derivatives thereof and their use
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313504A2 Methods and compositions for inhibiting angiogenesis
05/28/2003EP1313503A1 Human tumor necrosis factor receptors tr21 and tr22
05/28/2003EP1313497A1 Use of extracts of the cassia alata plant
05/28/2003EP1313489A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1212313B1 7-carboxy-flavone derivatives, preparation method and therapeutic use
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1105114B1 Nimesulide containing topical pharmaceutical compositions
05/28/2003EP1054678B1 Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
05/28/2003EP1032415B1 Composition for the treatment of allergic conditions with cysteine and serine proteinase inhibitors
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003EP0934061B1 Isobutylgaba and its derivatives for the treatment of pain
05/28/2003EP0869781B1 Transdermal device for the delivery of flurbiprofen
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003EP0690715B1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
05/28/2003CN1420891A Pharmaceutical compound
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420790A Transporters and drug delivery system by using same
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420776A Inhibition of cyclooxygenase-2 activity
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1420764A Pharmaceutical preparations and their manufacture
05/28/2003CN1420755A Method and composition for treatment of scars
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420358A Use of chemotaxin-oid factor-1 in inflammatory damage of organs
05/28/2003CN1419929A Method for preparing Chinese medicine composition for treating tetanic rachitis complicated necrosis of femoral head
05/28/2003CN1419909A Oral cavity disintegrating tablet of diclofenac for treating inflammation and pain, and preparing method thereof
05/28/2003CN1109680C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109550C Plaster for dispelling wind-evil and wetness-evil and stopping pain
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569900 Fulvic acid and its use in the treatment of various conditions
05/27/2003US6569890 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569888 Such as ethyl-N-(dichlorobenzyl)-4-(3-hydroxypropylthio) indole-2-carboxylate; for treatment of arthritis
05/27/2003US6569885 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569876 Method and structure for inhibiting activity of serine elastases
05/27/2003US6569871 Substituted imidazole compounds
05/27/2003US6569860 Alkoxycarbonylamino-heteroaryl carboxylic acid derivatives useful for treating the disorders of the urinary tract, pain, inflammation, respiratory states, edema formation, hypotensive vascular diseases, pain and allergies
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569849 N-Substituted azaheterocyclic compounds
05/27/2003US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease
05/27/2003US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease
05/27/2003US6569649 Compositions and methods for saccharide synthesis
05/27/2003US6569468 Treatment of urogenital disorders, menstrual cramps
05/27/2003US6569467 Modifying extracted blood aliquot extracorporeally by subjecting it to an immune system-modifying amount of ozone gas and ultraviolet radiation; reinjecting the vaccine into the patient; rheumatoid arthritis, psoriasis
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569437 Skin disorders
05/27/2003US6569416 Compositions containing synthetic soil-extract materials and medicaments based thereon
05/27/2003CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases
05/27/2003CA2268847C Substituted oximes derivatives useful as neurokinin antagonists
05/27/2003CA2110119C Antiinflammatory and analgesic gel preparation
05/27/2003CA2084961C Tissue protective tocopherol analogs
05/27/2003CA2031430C Process for refolding recombinantly produced tgf-.beta.-like proteins
05/22/2003WO2003042399A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042390A1 Mammalian protein phosphatases
05/22/2003WO2003042377A1 Expansion of t cells in vitro and expanded t cell populations
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042344A2 Apo2 ligand/trail formulations
05/22/2003WO2003042247A2 Modified anti-tnf alpha antibody
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/22/2003WO2003042187A1 Serin protease inhibitors
05/22/2003WO2003042179A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042176A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
05/22/2003WO2003042174A1 Cannabinoid receptor ligands
05/22/2003WO2003042173A1 Nk1 antagonists
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003041737A1 Treatment of inflammatory conditions
05/22/2003WO2003041726A1 Use of an extracellular adherence protein for the manufacture of an anti-inflammatory drug
05/22/2003WO2003041723A1 Pharmaceutical applications of hyaluronic acid preparations
05/22/2003WO2003041721A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041712A1 Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors
05/22/2003WO2003041708A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003WO2003041707A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
05/22/2003WO2003041705A1 Oral dosage form of a sulfonamide prodrug such as parecoxib
1 ... 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 ... 1272